The Chemours Aktie
15,71
EUR
-0,19
EUR
-1,20
%
18,95
USD
+0,62
USD
+3,36
%
Werbung
The Chemours Aktie Analyse
| 29.03.18 | The Chemours Outperform | BMO Capital Markets | |
| 07.08.17 | The Chemours Neutral | UBS AG | |
| 09.05.16 | The Chemours overweight | Barclays Capital | |
| 18.09.15 | The Chemours Hold | Argus Research Company | |
| 18.08.15 | The Chemours Sell | UBS AG |
Werbung
Werbung